NAV
315.07(1.95%)Fund Size (CR)
₹1,106.71Expense Ratio
1.29Scheme Type
Active FundValue Research
-
Min. investment
₹5,000Minimum Additional Investment
₹1,000Minimum SIP Investment
₹500Minimum Withdrawal
₹1Exit Load
1%Return Since Launch
15.17%
Basic Details
Scheme Manager
Kamal Gada
Bench Mark
BSE Healthcare TRI
Type
OPEN
Lumpsum Returns
| Period Invested For | ₹10,000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | March 17, 2026 | 9862.60 | -1.37% | - | -2.21% | 190/1003 |
| 1 Month | February 24, 2026 | 9650.35 | -3.50% | - | -8.48% | 56/987 |
| 3 Month | December 24, 2025 | 9565.32 | -4.35% | - | -9.86% | 123/964 |
| 6 Month | September 24, 2025 | 9349.29 | -6.51% | - | -8.56% | 309/920 |
| 1 Year | March 24, 2025 | 10075.87 | 0.76% | 0.76% | 0.86% | 381/860 |
| 3 Year | March 24, 2023 | 19894.44 | 98.94% | 25.74% | 17.44% | 36/518 |
| 5 Year | March 24, 2021 | 21001.26 | 110.01% | 15.99% | 14.75% | 148/430 |
| Since Inception | January 1, 2013 | 64803.48 | 548.03% | 15.17% | 7.11% | 225/1007 |
Note: Lumpsum Returns since Inception Date.
SIP Returns
| Period Invested For | ₹10,000 Invested on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | April 1, 2025 | 1,20,000 | 118876.91 | -0.94% | -0.94% |
| 3 Year | April 3, 2023 | 3,60,000 | 441862.81 | 22.74% | 7.07% |
| 5 Year | April 1, 2021 | 6,00,000 | 891034.08 | 48.51% | 8.23% |
| 10 Year | April 1, 2016 | 12,00,000 | 2877490.63 | 139.79% | 9.14% |
Note: SIP Returns since Inception Date.
Tax Treatment
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 10%, if your total long term capital gain exceeds 1 lakh. Any cess/surcharge is not included.If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 15%. Any cess/surcharge is not included in the 15%.
Mutual Funds Calculator
Monthly Investment (₹)
Expected Returns Rate (%)
Time Period (in Years)
Invested Amount
₹25,000
Estimated Returns
₹19,059
76%
Returns
Future value of your investment
₹44,059
Risk Ratios
4.53%
Standard Deviation
0.92%
Beta
1.17%
Sharpe Ratio
-0.01%
Treynor's Ratio
12.61%
Jension's Alpha
Asset Allocation
Sector Allocation
Top 10 stock holding in portfolio
| Stock Invested in | % of Total Holdings | Quantity | Value (Cr) | Asset Type | Segment |
|---|---|---|---|---|---|
| Sun Pharma.Inds. | 9.42% | 600000 | 104.22 | Equity | Pharmaceuticals |
| Ajanta Pharma | 7.04% | 260316 | 77.94 | Equity | Pharmaceuticals |
| Lupin | 5.79% | 278214 | 64.04 | Equity | Pharmaceuticals |
| Glenmark Pharma. | 4.25% | 220000 | 47.01 | Equity | Pharmaceuticals |
| Apollo Hospitals | 3.75% | 53000 | 41.45 | Equity | Healthcare |
| Gland Pharma | 3.54% | 215251 | 39.22 | Equity | Pharmaceuticals |
| Divi's Lab. | 3.52% | 60738 | 38.92 | Equity | Pharmaceuticals |
| Dr Reddy's Labs | 3.48% | 299461 | 38.52 | Equity | Pharmaceuticals |
| Alkem Lab | 3.47% | 68000 | 38.35 | Equity | Pharmaceuticals |
| Fortis Health. | 2.98% | 350000 | 32.99 | Equity | Healthcare |
Peer Comparison
| Scheme Name | Value Research | Asset Size (Cr) | 1M | 3M | 6M | 1Y | 3Y |
|---|---|---|---|---|---|---|---|
| UTI-Healthcare Fund - Direct (G) | 1106.71 | -3.50% | -4.35% | -6.51% | 0.76% | 25.74% | |
| Nippon India Taiwan Equity Fund - Direct (G) | 519.50 | 17.11% | 41.37% | 52.94% | 140.39% | 47.92% | |
| Nippon India Taiwan Equity Fund - Direct (IDCW) | 519.50 | 17.11% | 41.37% | 52.94% | 140.39% | 47.92% | |
| Franklin Asian Equity Fund - Direct (G) | 426.90 | -7.13% | 4.54% | 9.28% | 28.11% | 14.11% | |
| Franklin Asian Equity Fund - Direct (IDCW) | 426.90 | -7.13% | 4.54% | 9.28% | 28.10% | 14.10% | |
| Nippon India Japan Equity Fund - Direct (G) | 311.26 | -4.96% | 7.22% | 9.04% | 26.73% | 18.03% |
List of Schemes under UTI Mutual Fund
News
UTI Mutual Fund announces Appointment of Key Personnel
UTI Mutual Fund has announced that Mr. Ashish Shriram Thavkar has been designated as Vice President (Fund Manager & Research Analyst) has been identified as Key Personnel of UTI AMC, with effect from March 23, 2026.Details of Mr. Ashish Shriram Thavkar
Age: 46 years
Designation: Vice President (Fund Manager & Research Analyst)
Qualification: B.E, MBA (Finance) .
Powered by Capital Market - Live News
UTI Fixed Term Income Fund - Series XXXV ' I Merger into UTI Corporate Bond Fund
UTI Mutual Fund has approved the merger of UTI Fixed Term Income Fund - Series XXXV ' I Merger into UTI Corporate Bond Fund, with effect from 22 April 2026. and UTI Nifty SDL Plus AAA PSU Bond Apr 2026 75:25 Index Fund into UTI Floater Fund with effect from 30 April 2026.Powered by Capital Market - Live News
UTI Fixed Term Income Fund - Series XXXV ' I (1260 DAYS), into UTI Corporate Bond Fund and UTI Nifty SDL Plus AAA PSU Bond Apr 2026 75:25 Index Fund i
UTI Mutual Fund has approved the merger of UTI Fixed Term Income Fund - Series XXXV ' I (1260 DAYS), into UTI Corporate Bond Fund and UTI Nifty SDL Plus AAA PSU Bond Apr 2026 75:25 Index Fund into UTI Floater Fund, with effect from April 27, and 2026 April 30, 2026.Powered by Capital Market - Live News
Fund House Details & Investment Objective
Date of Incorporation
January 1, 2013
Total AUM (Cr)
₹1106.71
UTI-Healthcare Fund - Direct (G) is an Sectoral / Thematic-oriented fund from the renowned AMC, UTI Mutual Fund. Launched in January 1, 2013, this fund is managed by Kamal Gada. With assets under management (AUM) worth ₹1,106.71 (Cr), as of March 25, 2026, UTI-Healthcare Fund - Direct (G) is categorized as a Sectoral / Thematic within its segment. The fund has generated a return of 15.17% since its launch.
The current NAV of UTI-Healthcare Fund - Direct (G) is ₹315.07, as on March 25, 2026. The fund's benchmark index is BSE Healthcare TRI. You can invest in UTI-Healthcare Fund - Direct (G) via both lumpsum and SIP modes. The minimum SIP amount in the fund is ₹500 while the minimum lumpsum investment is ₹5,000.
Being an open-ended fund, you can exit the fund anytime subject to applicable exit loads:
The fund has generated 25.74% and 15.99% CAGR in the last 3 and 5 years respectively.
The fund aims to provide long-term capital appreciation and growth, by investing in a mix of financial instruments 98.21% in Equity, 1.80% in cash and cash equivalents.
The top 5 sectors the fund invests in are: 75.89% in Pharmaceuticals & Biotech, 22.65% in Healthcare Services, 1.20% in Cash & Others, 0.27% in Healthcare Equipment & Su, 0.01% in Others
Mutual Fund Categories
Types of Mutual Funds
Debt Funds
Access debt markets and enjoy interest income from bonds and debentures. Ideal for conservative short-term investors
Hybrid Funds
Enjoy best of both the worlds - equity and debt. Ideal for beginners with medium-term investment horizon
Equity Funds
Invest in large, mid, and small cap sector stocks to enjoy capital appreciation. Ideal for aggressive, long-term investors
